Zobrazeno 71 - 80
of 236
pro vyhledávání: '"Shuichi Miyawaki"'
Autor:
Masami Nakatsu, Hideaki Mizoguchi, Shuichi Miyawaki, Hiroko Shiozaki, Yuko Sato, Mian Zhou, Toshiko Motoji, Hiroshi Nakazato
Publikováno v:
British Journal of Haematology. 113:1076-1089
Autor:
Fumiharu Yagasaki, Yukiya Yamamoto, Tomoki Naoe, Hitoshi Kiyoi, Kenji Saito, Miki Nishimura, Yasuyuki Nakano, Ritsuro Suzuki, Yoshihisa Kodera, Ryuzo Ohno, Toshiko Motoji, Akihiro Takeshita, Hidehiko Saito, Shuichi Miyawaki, Ryuzo Ueda, Hideki Akiyama, Norio Asou, Chihiro Shimazaki, Katsuji Shinagawa, Kazutaka Kuriyama
Publikováno v:
Blood. 97:2434-2439
Mutations of receptor tyrosine kinases are implicated in the constitutive activation and development of human malignancy. An internal tandem duplication (ITD) of the juxtamembrane (JM) domain-coding sequence of the FLT3 gene (FLT3/ITD) is found in 20
Autor:
Manja Meggendorfer, Yasunobu Nagata, Seishi Ogawa, Inés Gómez-Seguí, Kenichi Chiba, Tetsuichi Yoshizato, Yusuke Sato, Hiromichi Suzuki, Yusuke Shiozawa, Swapna Thota, Shuichi Miyawaki, Satoru Miyano, Bartlomiej P Przychodzen, Holleh D Husseinzadeh, Masashi Sanada, Kenichi Yoshida, Cassandra M. Hirsch, Tsuyoshi Nakamaki, Kathryn M Guinta, Yogen Saunthararajah, Hiroko Tanaka, Aiko Sato-Otsubo, Claudia Haferlach, Lee-Yung Shih, Teodora Kuzmanovic, Wolfgang Kern, Yusuke Okuno, Tomas Radivoyevitch, Shigeru Chiba, Thomas LaFramboise, Yuichi Shiraishi, Jaroslaw P. Maciejewski, Torsten Haferlach, Brittney Dienes, Hideki Makishima, Naoko Hosono, Mikkael A. Sekeres
Publikováno v:
Blood. 128:4287-4287
Myelodysplastic syndromes (MDS) are a heterogeneous group of chronic myeloid neoplasms, in which disease progression is quite common, eventually terminating in secondary acute myeloid leukemia (sAML). To elucidate differential roles of mutations in M
Autor:
Kenichi Chiba, Yasushi Miyazaki, Mikkael A. Sekeres, Yuichi Shiraishi, Jaroslaw P. Maciejewski, Hideki Makishima, Hidehiro Itonaga, Kenichi Yoshida, Tetsuichi Yoshizato, Hiroko Tanaka, Tsuyoshi Nakamaki, Shigeru Chiba, Kathryn M Guinta, Yoshiko Atsuta, Makoto Onizuka, Yusuke Shiozawa, Lee-Yung Shih, Shuichi Miyawaki, Yoshinobu Kanda, Satoru Miyano, Ryunosuke Saiki, Seishi Ogawa
Publikováno v:
Blood. 128:955-955
Background Copy number alteration (CNA) is a hallmark of cancer genomes and has been implicated in the development of human cancers, including myeloid neoplasms. We developed a novel, next-generation sequencing-based platform for highly sensitive det
Autor:
Akira Hangaishi, Kenichi Chiba, Yasunobu Nagata, Michael Heuser, Yusuke Shiozawa, Satoru Miyano, Keisuke Kataoka, Hiroko Tanaka, Tetsuichi Yoshizato, Ken Ishiyama, Felicitas Thol, Kenichi Yoshida, Seishi Ogawa, Shuichi Miyawaki, Yuichi Shiraishi, June Takeda, Masashi Sanada, Kensuke Usuki, Arnold Ganser
Publikováno v:
Blood. 128:40-40
Introduction Acute erythroid leukemias (AELs) are infrequent acute leukemias characterized by a predominant erythroid population, dysplasticity and ring sideroblasts. The 2016 revision of the World Health Organization (WHO) Classification re-classifi
Autor:
Toru Sakura, Tomoki Naoe, Tomoya Maeda, Yasushi Miyazaki, Kinya Ohata, Maki Hagihara, Yukiyasu Ozawa, Shigeki Ohtake, Toshi Imai, Kazunori Ohnishi, Yoshikazu Ito, Sumihisa Honda, Hitoshi Kiyoi, Shin Fujisawa, Katsumichi Fujimaki, Hiroyuki Fujita, Shuichi Miyawaki, Asao Hirose, Hideaki Nakajima, Nobuaki Dobashi
Publikováno v:
Blood. 128:2795-2795
Background The percentage of blasts in the bone marrow in the early stage of remission induction therapy for acute myeloid leukemia (AML) has been reported to affect not only remission rate, but also long-term prognosis. If early post-treatment respo
Autor:
Tomoki Naoe, Shigeki Ohtake, Kinya Ohata, Maki Hagihara, Yasushi Miyazaki, Kazunori Ohnishi, Shuichi Miyawaki, Tomoya Maeda, Dobashi Nobuaki, Shin Fujisawa, Yukiyasu Ozawa, Asao Hirose, Hideaki Nakajima, Toru Sakura, Iekuni Ou, Sumihisa Honda, Hitoshi Kiyoi, Yoshikazu Ito, Kenji Matsumoto, Noriko Doki
Publikováno v:
Blood. 128:1616-1616
Introduction: Acute myeloid leukemia (AML) with hyperleukocytosis is considered to have a poor prognosis due to a high early death rate secondary to complications such as disseminated intravascular coagulation (DIC), tumor lysis syndrome (TLS), and l
Publikováno v:
Blood. 128:1643-1643
Acute myeloid leukemia (AML) is the most common leukemia in older adults. Chemotherapy is the standard treatment, however, treatment efficacy and tolerability deteriorates with age, and patients are susceptible to relapse after complete remission (CR
Autor:
Yukio Kobayashi, Hisashi Sakamaki, Masatomo Takahashi, Masafumi Taniwaki, Shunichiro Yamaguchi, Shuichi Miyawaki, Norio Asou, Shigeki Ohtake, Noriyoshi Iriyama, Tomoya Maeda, Yasushi Miyazaki, Sumihisa Honda, Yoshihiro Hatta, Tomoki Naoe, Toru Sakura, Shinya Sato, Kazunori Ohnishi, Tomohiko Taki, Hiroshi Handa
Publikováno v:
Annals of hematology. 93(6)
Recently, the presence of CEBPA mutation was identified as an important prognostic factor for normal karyotype (NK) acute myeloid leukemia (AML). Because AML with CEBPA mutation is closely associated with CD7, CD15, CD34, and HLA-DR expression, we in
Autor:
Shuichi, Miyawaki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 54(10)